CD34 stem cell-related methods and compositions

US7998472B2 · kind B2 · utility

Assignee

• APCETH GMBH & CO. KG · DE

Inventors

• Ralf Huss · Waakirchen, DE
• Matthias C. Raggi · Birkenfeld, DE
• Manfred STANGL · Sauerlach, DE
• Peter C. Nelson · Munich, DE

Key dates

• Filing date: May 20, 2008
• Grant date: Aug 16, 2011
• Expiry date: May 20, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K2035/124
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34− stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34− stem cells used in the instant methods can be genetically modified or not, depending on the disorder treated.